3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 1/2
4
Phase 3
3
Status
Completed
3
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Prostatic Neoplasms
3
Neoplasms
1
Interventions
Cisplatin
187
Carboplatin
182
Paclitaxel
177
Docetaxel
145
Cyclophosphamide
129
Dexamethasone
117
pembrolizumab
106
Doxorubicin
103
Bevacizumab
103
Gemcitabine
102
Rituximab
96
Prednisone
87
Fluorouracil
86
Pemetrexed
82
Radiotherapy
77
Vincristine
71
Etoposide
71
Capecitabine
69
Nivolumab
68
Trastuzumab
67
Leucovorin
64
Cytarabine
57
Methotrexate
52
Oxaliplatin
49
atezolizumab
48
Lenalidomide
43
Ipilimumab
40
Filgrastim
40
Bortezomib
39
Sorafenib
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Has results
×
XRP6258
×
Clear all
NCT01308567
2019-06-05
FIRSTANA
Sanofi
Phase 3
Completed
1,168 enrolled
17 charts
NCT01308580
2017-04-17
PROSELICA
Sanofi
Phase 3
Completed
1,200 enrolled
25 charts
NCT00417079
2011-03-10
TROPIC
Sanofi
Phase 3
Completed
755 enrolled
19 charts